NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: BYND 21.95%
NASDAQ: ACXIF 21.95%
NASDAQ: BATL 21.95%
NASDAQ: KORE 21.95%
NASDAQ: NGNE 21.95%
